These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5973827)

  • 1. [Insulin activity with antibody-suppressible insulin activity and immunologically measurable insulin in the pancreas and serum of genetically obese and hyperglycemic mice].
    Stauffacher W; Vecchio DA; Zahnd GR; Renold AE
    Helv Physiol Pharmacol Acta; 1966; 24(2):C53-4. PubMed ID: 5973827
    [No Abstract]   [Full Text] [Related]  

  • 2. Disappearance of serum insulin in obese-hyperglycemic mice.
    Coore HG; Westman S
    Acta Physiol Scand; 1970 Feb; 78(2):274-9. PubMed ID: 5456891
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine abnormalities in the pancreas and gut of the obese hyperglycaemic (ob/ob) mouse [proceedings].
    Adrian TE; Bryant MG; Bloom SR
    J Endocrinol; 1979 May; 81(2):156P. PubMed ID: 458334
    [No Abstract]   [Full Text] [Related]  

  • 4. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of immunoreactive insulin in obese hyperglycemic laboratory rodents.
    Cameron DP; Stauffacher W; Amherdt M; Orci L; Renold AE
    Endocrinology; 1973 Jan; 92(1):257-64. PubMed ID: 4681931
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoreactive growth hormone levels in mice with the obese-hyperglycemic syndrome (genotype obob).
    Roos P; Martin JM; Westman-Naeser S; Hellerström C
    Horm Metab Res; 1974 Mar; 6(2):125-8. PubMed ID: 4208127
    [No Abstract]   [Full Text] [Related]  

  • 7. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
    Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin and its cellular receptors in changes in glucose metabolism].
    de Pabio F; Roth J; Hedo JA
    Rev Clin Esp; 1981 Aug 15-31; 162(3-4):79-88. PubMed ID: 7031791
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on carbohydrate and fat metabolic changes of hereditary obese hyperglycemic mice.
    Kamioka T; Ogura K; Tani E; Matsushita H
    Wakayama Med Rep; 1968 Mar; 12(4):173-82. PubMed ID: 5659917
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects.
    Iannello S; Milazzo P; Belfiore F
    Obes Rev; 2007 May; 8(3):231-51. PubMed ID: 17444965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice.
    Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH
    Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes.
    Gosmanov AR; Umpierrez GE; Karabell AH; Cuervo R; Thomason DB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E8-E15. PubMed ID: 15010337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic tolbutamide administration on normal and obese-hyperglycemic mice: evidence for post-receptor potentiation of insulin action.
    Poyet C; Feldman JM
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):355-76. PubMed ID: 7043679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of insulin activities in pancreas and serum of mice with spontaneous ("Obese" and "New Zealand Obese") and induced (Goldthioglucose) obesity and hyperglycemia, with considerations on the pathogenesis of the spontaneous syndrome.
    Stauffacher W; Lambert AE; Vecchio D; Renold AE
    Diabetologia; 1967 Apr; 3(2):230-7. PubMed ID: 5630191
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative histochemistry of the endocrine pancreas.
    Gepts W; Grégoire F
    Curr Probl Clin Biochem; 1971; 3():284-311. PubMed ID: 4950900
    [No Abstract]   [Full Text] [Related]  

  • 17. Glomerulosclerosis in a strain of genetically diabetic mice.
    Camerini-Davalos RA; Oppermann W; Treser G; Ehrenreich T; Lange K; Levine R
    Diabetes; 1968; 17():301. PubMed ID: 5651718
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of appetite and insulin signaling in inflammatory states.
    Teli T; Xanthaki D; Karalis KP
    Ann N Y Acad Sci; 2006 Nov; 1083():319-28. PubMed ID: 17148747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxidative phosphorylation of liver mitochondria from obese-hyperglycemic mice].
    Ogura I
    Nihon Seirigaku Zasshi; 1968; 30(6):393-8. PubMed ID: 5750201
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.